• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDrugs

Drugs

Page 30 of 32
Merck
Features
Merck halts study in light of melanoma drug’s success
By Laura LorenzettiMarch 24, 2015
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
Features
How Biogen scored the most successful Alzheimer’s drug so far
By Jen WiecznerMarch 20, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance
Valeant comes out a winner after upping its Salix bid to $11.1 billion
By Laura LorenzettiMarch 16, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
Features
FDA approves the first biosimilar for the U.S. market
By Laura LorenzettiMarch 6, 2015
IL: Corporations In Illinois
Finance
AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal
By ReutersMarch 4, 2015
Inside Rite Aid Ahead of Earnings Reports
Retail
Rite Aid takes aim at CVS with a $2 billion purchase
By Laura LorenzettiFebruary 11, 2015
161135392
Features
Biosimilars may one day save your life. But what are they?
By Laura LorenzettiFebruary 6, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance
After Allergan loss, is Valeant dumpster diving?
By Jen WiecznerJanuary 31, 2015
Picture taken on January 15, 2012 in Lil
Commentary
How to stop generic drug shortages: end hospital group purchasing kickbacks 
By Phillip L. Zweig and Robert A. CampbellJanuary 30, 2015
Los Angeles City Council Votes To Ban Medical Marijuana Dispensaries
Retail
Report predicts 18 states will legalize pot by 2020
By TIMEJanuary 26, 2015
Regeneron vaults ahead of Amgen in race to market cholesterol drug
Features
Regeneron vaults ahead of Amgen in race to market cholesterol drug
By ReutersJanuary 26, 2015
Los Angeles City Council Votes To Ban Medical Marijuana Dispensaries
Retail
High stakes: How this marijuana company gained buzz in a budding market
By Entrepreneur and Ben GeierDecember 26, 2014
FedEx Reports Sharp Decline In Quarterly Profits
Leadership
The war on drugs comes to Corporate America
By Chris MatthewsDecember 2, 2014
Images Of Over-The-Counter Medicines And Dietary Supplements By Japanese Drugmakers
Features
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By Laura LorenzettiDecember 2, 2014
ArcelorMittal facility
Finance
Merck buys the rights to an experimental Ebola vaccine
By ReutersNovember 24, 2014
1...
  • 28
  • 29
  • 30
  • 31
  • 32
32
Most Popular
Success
A dropout living in a trailer, he got $1 million from Peter Thiel at 19—now he's a billionaire who says the American Dream isn't deadplaceholder alt text
By Orianna Rosa RoyleAugust 18, 2026
Energy
U.S. strategic reserves are getting so low the drawdown threatens to damage the 60 underground salt caverns storing American oilplaceholder alt text
By Sasha RogelbergAugust 17, 2026
Personal Finance
Current price of oil as of August 18, 2026placeholder alt text
By Joseph HostetlerAugust 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.